🇧🇷 Ocupress in Brazil

Ocupress (CARTEOLOL) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Ocupress in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in Brazil

Frequently asked questions

Is Ocupress approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Ocupress in Brazil?

Marketing authorisation holder not available in our data.